| Literature DB >> 3825989 |
S B Lele, M S Piver, J Malfetano.
Abstract
Twenty-five patients with FIGO stage III and IV ovarian carcinoma were treated with cisplatin plus VP16-213 chemotherapy as the second, third, or fourth line of therapy. There were two (8%) partial responses, 18 with stable disease and five with progression of disease. Neurotoxicity was observed in all patients, with two patients developing severe paresthesias and difficulty in walking.Entities:
Mesh：
Substances：
Year: 1987 PMID： 3825989 DOI： 10.1097/00000421-198702000-00004
Source DB: PubMed Journal: Am J Clin Oncol ISSN： 0277-3732 Impact factor: 2.339